Issuu on Google+

PG Diploma / MSc in Advanced Pharmacy Practice (with Independent Prescribing)

SCHOOL OF PHARMACY QUEEN’S UNIVERSITY BELFAST


CONTENTS

Page 1.0

Introduction

1

1.1

Rationale for introduction of this programme

1

1.2

Programme structure

3

1.3

Programme delivery

4

1.4

Programme specifications

4

1.5

Business plan

4

1.6

Market intelligence report

4

Appendices: 1

Advanced and Consultant Level Framework (ACLF)

5

2

Module descriptions

26

3

Programme specification – PG Diploma

39

4

Programme specification – MSc

45

5

Programme learning outcomes mapped to programme modules

51

6

Market Intelligence Report

55


1.0 Introduction The School of Pharmacy is seeking to introduce a new PG Diploma / MSc in Advanced Pharmacy Practice (with Independent Prescribing), with the first intake due to commence in October 2010. The new programme will complement the School’s current clinical and community pharmacy MSc programmes and will meet a requirement for advanced practice training for NHS pharmacists. 1.1 Rationale for introduction of this programme The School of Pharmacy provides postgraduate education and training for hospital pharmacists via 2 routes. Firstly, the School’s part-time MSc in Clinical Pharmacy is a popular programme for the postgraduate education of hospital pharmacists who wish to practice as clinical pharmacists in the UK and beyond. Approximately 40 hospital pharmacists from Northern Ireland are registered on this programme each year. Secondly, the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD), which is located within the School of Pharmacy, provides postgraduate training for all pharmacists in Northern Ireland, including hospital pharmacists. The programmes provided by NICPLD include a prescribing course for both hospital and community pharmacists and the Northern Ireland Hospital Pharmacists’ Vocational Training Scheme. The prescribing course trains pharmacists who wish to become non-medical prescribers and trainees are also registered for the award of a PG Certificate in Prescribing for Pharmacists. This course has an annual intake of approximately 20 students. The VT Scheme has been in existence for 2 years and provides training for new hospital pharmacists in Northern Ireland. There have been 2 intakes to date, with 12 and 18 trainees recruited in each year. Due to the relatively small number of hospital pharmacists in Northern Ireland, and the fact that until recently QUB was the only School of Pharmacy in Northern Ireland, staff in the School have maintained a close relationship with hospital pharmacists in Northern Ireland and, indeed, many senior hospital pharmacists contribute to the development of learning materials and the assessment of these programmes. The role of the pharmacist in the NHS is expanding, with hospital pharmacists becoming more involved in direct patient care and in Integrated Medicines Management, whereby pharmacists are involved throughout the patient journey, from admission to discharge. Prescribing is a key new role for hospital pharmacists and pharmacist-led clinics have been introduced in recent years. While the demand for the School’s clinical pharmacy programme has been high in recent years, staff are aware that NHS managers are seeking educational programmes that require students to develop both their knowledge and skills, as opposed to the more traditional, knowledge-based programmes. The School’s Distance Learning Manager (who is responsible for the delivery of the Clinical Pharmacy programme) and staff from NICPLD met with NHS Trust Pharmacy Managers in early 2009 to discuss postgraduate education for hospital pharmacists and it was apparent that there is a need for postgraduate education that not only provides students with the knowledge required to provide clinical services but also with the skills required to operate in a multidisciplinary environment and to deliver effective services directly to patients. Under Agenda for Change (AfC), introduced in the NHS in 2004, hospital pharmacists are placed in pay bands on the basis of the knowledge and skills needed to do their job. Each

1


post has a Knowledge and Skills Framework (KSF) outline that identifies the knowledge and skill requirements for it and each post holder has an annual review against their KSF outline to identify any development needs. At two points on each of the AfC pay bands, incremental progression is dependent on fulfilling the appropriate KSF outline for the post. Pharmacists enter the NHS at Band 6 and may progress as follows: Band 6 (General Pharmacist) Band 7 (Specialist Pharmacist) Band 8a (Advanced Pharmacist) Band 8b (Pharmacist Team Leader) Band 8c/8d/9 (Consultant Pharmacist / professional manager) In order to support the professional development of hospital pharmacists, two competency frameworks have been developed by the Competency Development and Evaluation Group (CoDEG), a collaborative network of specialist and academic pharmacists, researchers and practitioners based in London. The first, the General Level Framework (GLF) supports the development from registered pharmacist to General Pharmacist and has been mapped to the KSF outline for Band 6 pharmacists. The second, the Advanced and Consultant Level Framework (ACLF), supports development beyond Band 6 and identifies competencies at Foundation, Excellence and Mastery levels. The Foundation level has been mapped to the KSF outline for Band 7 pharmacists and the Excellence level has been mapped to the KSF outline for Band 8a pharmacists. The ACLF consists of six competency clusters: Expert Professional Practice; Building Working Relationships; Leadership; Management; Education, Training and Development; and Research and Evaluation (Appendix 1). CoDEG have defined the ‘Advanced Pharmacist Practitioner’ as having highly specialised or highly developed knowledge and skills encompassing the breadth and depth of current and future professional practice, although at present there is no formal recognition by the current regulator. The ‘Advanced Pharmacist Practitioner’ is expected to demonstrate attainment on the ACLF of a minimum of five clusters at ‘Excellence’ and one at ‘Foundation’ level. The Joint Programmes Board (JPB) is a consortium of Higher Education Institutes in London, the East and South East regions of England, and the NHS. Its remit is to develop and deliver unified post-registration education to pharmacy practitioners across these regions. The JPB has developed the PG Diploma in General Pharmacy Practice, which is linked to the GLF and therefore is targeted at Band 6 pharmacists. The JPB Diploma in General Pharmacy Practice can be considered as being equivalent to the Northern Ireland Hospital Pharmacists’ Vocational Training Scheme (and also the Stage II Scottish Hospital Pharmacists’ Vocational Training Scheme), which is similarly based on the GSF and is targeted at Band 6 pharmacists. In addition to the Diploma in General Pharmacy Practice, the JPB launched the MSc in Advanced Pharmacy Practice “fast-track” programme in October 2008. This programme was initially targeted at pharmacists in Band 8 posts, however, pharmacists with more than 24 months experience in Band 7 posts were permitted to apply for October 2009 entry. The aim of this programme is to support pharmacists in attaining ‘Excellence’ according to the ACLF criteria and it is designed on the philosophy of work-based learning. All applicants must have a suitable previous PG Diploma or must submit a portfolio of evidence of prior learning and

2


experience to an APCL/APEL panel. Up to 120 credits were available via APCL/APEL. The “fast-track” programme pre-empted the introduction of a full MSc in Advanced Pharmacy Practice in October 2009. This programme is targeted at Band 7 and Band 8 pharmacists and also aims to support pharmacists in attaining ‘Excellence’ according to the ACLF criteria. It appears that the rationale for the “fast-track” programme was to ensure that there would be a sufficient number of pharmacists able to mentor students on the full MSc in Advanced Pharmacy Practice programme. Several other Schools of Pharmacy in GB have developed, or are developing Advanced Practitioner development programmes based on the ACLF. Staff in the School are concerned that these programmes offer an alternative to the existing knowledge-based clinical pharmacy programme that may be attractive to employers and this may result in a decrease in the number of students recruited to the School’s clinical pharmacy programme. Therefore, in order to meet the demand from NHS employers for more skills-based postgraduate education and to meet the challenge of competition from Schools of Pharmacy in GB, the School of Pharmacy is seeking to introduce a new MSc in Advanced Pharmacy Practice (with Independent Prescribing) that will facilitate pharmacists in attaining ‘Advanced Practitioner’ status, based on the ACLF competencies in addition to enabling graduates to register as Independent Prescribers with the Pharmaceutical Society of NI or the RPSGB. It is envisaged that this programme will be a natural progression for pharmacists who complete the NI Hospital Pharmacists’ Vocational Training Scheme. The VT scheme has previously been assessed by an APCL panel within the School as being equivalent to a PG Certificate and therefore successful VT pharmacists will be entitled to 60 credit points. In addition, pharmacists in Band 7 posts in Northern Ireland who do not have a previous PG Diploma will be considered for entry via APCL/APEL. 1.2 Programme structure The MSc in Advanced Pharmacy Practice will be a part-time programme, 30 months in duration. Applicants who have completed the NI Hospital Pharmacists’ Vocational Training Scheme and Band 7 pharmacists who have been assessed as having sufficient previous qualifications and/or experience will receive 60 points credit. The additional 60/120 credit points required for a PG Diploma/MSc award will be accrued as follows: PG Diploma: PMY7040 (Advanced Therapeutics) PMY7054 (Clinical Management Planning) PMY7055 (Prescribing and Monitoring) PMY7056 (Disease Management) PMY7057 (Professional Aspects)

(20 points) (10 points) (10 points) (10 points) (10 points)

MSc: PMY7041 (Research in Advanced Practice) PMY7042 (Advanced Practice Development) PMY7043 (Practice Research Project)

from existing prescribing course

(10 points) (20 points) (30 points)

3


The programme timescale is as follows: PMY7040 (Advanced Therapeutics) PMY7054 (Clinical Management Planning) PMY7055 (Prescribing and Monitoring) PMY7056 (Disease Management) PMY7057 (Professional Aspects) MSc: PMY7041 (Research in Advanced Practice) PMY7042 (Advanced Practice Development) PMY7043 (Practice Research Project)

(Oct - Mar) (Apr - Dec) per existing prescribing course

(Jan - Mar) (Apr - Mar) (Apr - Mar)

Module descriptions are included in Appendix 2. 1.3 Programme delivery The programme will be delivered via a combination of distance learning, e-learning, workbased learning and on-campus workshops. Local clinical pharmacy specialists will develop the learning materials for PMY7040 by adapting existing materials from the School’s distance learning clinical pharmacy programme. In addition, the learning materials will be supported by three on-campus workshops and e-learning materials. Modules PMY7054/5/6/7 currently form the NICPLD prescribing course and will be used without adaptation. Modules PMY7041 and PMY7043 will be developed within the School and will be based on existing materials from the clinical pharmacy programme. Module PMY7042 will be developed by staff from NICPLD. Students will undertake self-directed learning in accordance with an agreed Personal Development Plan. In addition, the learning materials will be supplemented by on-campus workshops and e-learning materials. 1.4 Programme Specifications Programme Specifications for the PG Diploma and MSc pathways are included in Appendices 3 and 4 respectively. The programme learning outcomes are mapped to programme modules in Appendix 5. 1.5 Business Plan This programme will be developed and delivered using existing resources within the School. There are no additional resources required and Marie Canavan (Management Accountant) has indicated that a business plan is not required for approval purposes. 1.6 Market Intelligence Report A Market Intelligence Report was carried out by Marketing and Communications in June 2009 – see Appendix 6.

4


APPENDIX 1 ADVANCED AND CONSULTANT LEVEL FRAMEWORK (ACLF)

5


APPENDIX 2 MODULE DESCRIPTIONS

26


Module Code: Module Title: Delivered by: CAT Points: Status: Pre-requisites: Co-requisites:

PMY7040 Advanced Therapeutics Distance Learning Centre, School of Pharmacy 20 Pending approval None None

Module description: Pathophysiology, diagnosis, drug treatment and clinical management of diabetes and common respiratory, cardiovascular and infectious diseases, including: • • • • • • • • • • • • • • • •

Asthma Chronic Obstructive Pulmonary Disease (COPD) Type 1 diabetes mellitus Type 2 diabetes mellitus Acute complications of diabetes mellitus Long-term complications of diabetes mellitus Coronary heart disease Essential hypertension Acute coronary syndromes Arrhythmias Angina Heart failure Upper respiratory tract infections Lower respiratory tract infections Urinary tract infections Clostridium difficile-associated disease

In addition, this module will include antimicrobial resistance and prevention and control of infection. Learning outcomes: On completion, students will be able to: • •

• • •

Demonstrate specialist pharmaceutical knowledge in the care of patients with diabetes and common respiratory, cardiovascular and infectious diseases. Plan, manage, monitor, advise and review specialist pharmaceutical care programmes for patients with diabetes and common respiratory, cardiovascular and infectious diseases. Deliver pharmaceutical care to patients with diabetes and common respiratory, cardiovascular and infectious diseases. Demonstrate a holistic approach to patient care. Implement professional policies/procedures and clinical guidelines.

27


Skills: Students will develop their analytical, judgemental and interpretational skills and will be able to demonstrate the application of decision-making skills in complex situations. Teaching and learning methods: Students study directed reading which is designed to provide an evidence-based knowledge of the pathophysiology, diagnosis, drug treatment and clinical management of diabetes and common respiratory, cardiovascular and infectious diseases. The module includes workshops designed to develop the advanced-level clinical skills that are appropriate for the pharmaceutical care of patients with these diseases. In addition, e-learning is used to deliver video resources and to allow students to undertake formative self-assessment. Assessment: The therapeutic knowledge and skills will be assessed via a combination of multiple choice examination and an Observed Structured Clinical Examination. In addition, students are required to demonstrate the application of their knowledge and skills in their clinical practice via completion and submission of a portfolio of evidence. The assessments will contribute to the overall module mark as follows: MCQ Examination OSCEs Portfolio

30% 40% 30%

Resources: Module tutors. Supplementary notes: This learning outcomes and skills taught in this module are based on the competencies defined in the Advanced and Consultant Level Framework (ACLF) clusters 'Expert Professional Practice' and 'Building Working Relationships'. The module has been designed to ensure that students achieve a minimum of ‘Foundation’ standard in the ACLF competencies.

28


Module Code: Module Title: Delivered by: CAT Points: Status: Pre-requisites: Co-requisites:

PMY7054 Clinical Management Planning NICPLD, School of Pharmacy 10 Live None None

Module description: Students study self-teaching material relating to the development of the Clinical Management Plan as part of a multidisciplinary approach to patient care. Learning outcomes: On completion the student will be able to: • • • • •

Develop and document a Clinical Management Plan (CMP) / Treatment Plan (TP) Describe the roles of other healthcare professionals in developing the CMP/TP Identify models of consultation Discuss the principles of diagnosis Assess responses to treatment against the objectives of the CMP/TP.

Skills: Students will develop the following skills: • • •

Oral and written communication to professional and non-professional audiences Patient consultation Working in a multidisciplinary team

Teaching and learning methods: On-line theory via e-learning with tutor support plus three days of live workshops. Practice-based portfolio Assessment: Knowledge is assessed via an on-line MCQ exam. Application of knowledge is assessed via development of a Clinical Management Plan / Treatment Plan. The assessments will contribute to the overall module mark as follows: MCQ Examination Clinical Management Plan

25% 75%

Resources: E-learning web site Module tutors (workshops) In-practice training Supplementary notes: This module is delivered as one element of the training course for pharmacists in Northern Ireland who wish to register as Independent Prescribers with the Pharmaceutical Society of Northern Ireland (PSNI) or the Royal Pharmaceutical Society of Great Britain (RPSGB). The learning outcomes and skills are defined in the RPSGB indicative syllabus and the course is accredited on a 3-yearly basis by the PSNI/RPSGB.

29


Module Code: Module Title: Delivered by: CAT Points: Status: Pre-requisites: Co-requisites:

PMY7055 Prescribing and Monitoring NICPLD, School of Pharmacy 10 Live None None

Module description: Students study e-learning material relating to the influences on, and psychology of, prescribing. In addition, students receive instruction on relevant physical examination and patient monitoring skills. Learning outcomes: On completion students will be able to describe and discuss the influences on, and psychology of, prescribing. In addition, they will be able to carry out a range of physical examination and patient monitoring techniques and take appropriate action based on the results. Skills: Students will develop the following skills: • •

Physical examination skills Decision making skills

Teaching and learning methods: On-line theory via e-learning plus two days instruction in the QUB Clinical Teaching Laboratory. Practice-based portfolio Assessment: Knowledge is assessed via an on-line MCQ exam. Application of knowledge and physical examination skills are assessed via an Objective Structured Clinical Examination (OSCE). The assessments will contribute to the overall module mark as follows: MCQ Examination OSCE

50% 50%

Resources: E-learning web site Module tutors QUB Clinical Skills Laboratory (School of Nursing) In-practice training Supplementary notes: This module is delivered as one element of the training course for pharmacists in Northern Ireland who wish to register as Independent Prescribers with the Pharmaceutical Society of Northern Ireland (PSNI) or the Royal Pharmaceutical Society of Great Britain (RPSGB). The learning outcomes and skills are defined in the RPSGB indicative syllabus and the course is accredited on a 3-yearly basis by the PSNI/RPSGB.

30


Module Code: Module Title: Delivered by: CAT Points: Status: Pre-requisites: Co-requisites:

PMY7056 Disease Management NICPLD, School of Pharmacy 10 Live None None

Module description: Prior to commencing the Independent Prescribing course, students are required to identify a maximum of 2 therapeutic areas in which they intend to prescribe. Students identify personal learning outcomes relevant to their chosen therapeutic areas and undertake self-study that enables them to prescribe and modify therapy for identified disease conditions. Learning outcomes: On completion the student will be able to: • • • •

Describe the pathophysiology, natural history and progression of the conditions for which they intend to prescribe Apply the principles of clinical pharmacology to select appropriate drug regimes Assess response to therapy and modify as appropriate Identify and report adverse drug reactions and interactions.

Skills: Students will develop the following skills: • •

Written communication Independent learning

Teaching and learning methods: E-learning Self-directed learning Practice-based portfolio Assessment: Knowledge is assessed via an on-line MCQ system and application of knowledge is assessed via a structured clinical case. Students must provide evidence of a minimum of 30 hours self-directed learning applicable to each of the therapeutic areas in which they intend to prescribe. The assessments will contribute to the overall module mark as follows: MCQ Examination Clinical case study

25% 75%

Resources: E-learning web site plus self-directed learning resources. In-practice training Supplementary notes: This module is delivered as one element of the training course for pharmacists in Northern Ireland who wish to register as Independent Prescribers with the Pharmaceutical Society of Northern Ireland (PSNI) or the Royal Pharmaceutical Society of Great Britain (RPSGB). The learning outcomes and skills are defined in the RPSGB indicative syllabus and the course is accredited on a 3-yearly basis by the PSNI/RPSGB.

31


Module Code: Module Title: Delivered by: CAT Points: Status: Pre-requisites: Co-requisites:

PMY7057 Professional Aspects NICPLD, School of Pharmacy 10 Live None None

Module description: Students study e-learning material that enables them to prescribe safely using appropriate evidencebased practice, and to prescribe within a legal and ethical framework. Learning outcomes: On completion students will be able to: • • • • •

Apply critical appraisal skills in evidence-based practice Understand the framework for practice budgets and cost-effective prescribing Audit, monitor and evaluate their prescribing practice Discuss the principles of risk management Prescribe within a legal and ethical framework.

Skills: Students will develop the following skills: • • • •

Written communication Critical appraisal Decision-making Independent learning

Teaching and learning methods: On-line theory via e-learning plus 2 days of on-campus workshops. Practice-based portfolio Assessment: Knowledge and skills are assessed via a structured professional decision-making exercise and a critical appraisal exercise. The assessments will contribute to the overall module mark as follows: Decision-making assignment Critical appraisal assignment

50% 50%

Resources: E-learning web site In-practice training Supplementary notes: This module is delivered as one element of the training course for pharmacists in Northern Ireland who wish to register as Independent Prescribers with the Pharmaceutical Society of Northern Ireland (PSNI) or the Royal Pharmaceutical Society of Great Britain (RPSGB). The learning outcomes and skills are defined in the RPSGB indicative syllabus and the course is accredited on a 3-yearly basis by the PSNI/RPSGB.

32


Module Code: Module Title: Delivered by: CAT Points: Status: Pre-requisites: Co-requisites:

PMY7041 Research in Advanced Practice Distance Learning Centre, School of Pharmacy 10 Pending approval None None

Module description: Clinical and pharmacy practice research methodology including: • • • • • • •

Formulation of research questions Quantitative research techniques Qualitative research techniques Clinical and practice audit Statistical analysis of data Project management Research governance and ethics

The module aims to prepare students for the ‘Service research and development’ module. Learning outcomes: On completion of this module, students will be able to: • • • • • • •

Describe the stages of the research process and how they are managed Formulate a research hypothesis Select appropriate research methods to generate data Explain how a representative sample may be obtained from the population under study Design a survey questionnaire and select an appropriate administration method Select and employ appropriate statistical methods Describe the ethical considerations of research

Skills: Students will develop the following skills: • • •

Written communication Reflective thinking Statistical analysis

Teaching and learning methods: On-line theory via e-learning

33


Assessment: Knowledge and skills will be assessed via (i) the development of a research protocol for a potential service audit or research project, (ii) a case study on research ethics and (iii) statistical analysis of clinical data. The assessments will contribute to the overall module mark as follows: Research protocol Ethics case study Statistics coursework

40% 30% 30%

Resources: E-learning web site Supplementary notes: This learning outcomes and skills taught in this module are based on the competencies defined in the Advanced and Consultant Level Framework (ACLF) cluster 'Research and Evaluation'. The module has been designed to ensure that students achieve 'excellence' standard in the ACLF competencies.

34


Module Code: Module Title: Delivered by: CAT Points: Status: Pre-requisites: Co-requisites:

PMY7042 Advanced Practice Development NICPLD, School of Pharmacy 20 Pending approval None PMY7043 (Practice Research project)

Module description: At the start of the module, students will use the ACLF competencies to identify their individual learning needs and to develop their Personal Development Plan (PDP). The module will support pharmacists to develop competence in the provision of advanced pharmaceutical care, and will focus on the following areas: Building Working Relationships • Working within a multidisciplinary team Education, Training & Development • Role modelling and it’s place in learning and development • Mentoring: The mentoring process, mentoring definitions • Skills for mentoring, tutoring and supporting learning: questioning, listening, feedback, appraisal skills • Assessment methods • Principles of teaching and learning • Principles of student-centred learning and how to support this effectively Management & Leadership • Essentials of Leadership: vision, innovation and motivational skills • Strategic context & planning • Service development • Managing change • Working across boundaries • Clinical Governance and Risk Management • Resources utilisation • Performance management Learning outcomes: On completion of this module, students will be able to: • • • • • •

Demonstrate the ability to work as an acknowledged member of a multidisciplinary team Apply leadership skills within a team environment Manage resources effectively Identify and manage risk Plan and deliver effective learning experiences for pharmacists and other professionals Take responsibility for their learning and ongoing CPD

35


Skills: Students will develop the following skills: • • • • •

Multidisciplinary team-working Leadership Risk management Oral and written communication / presentation skills Independent learning

Teaching and learning methods: At the outset, students will develop a Personal Development Plan (PDP) in collaboration with their line manager. Students undertake self-directed learning in accordance with their PDP. Workshops will cover the underpinning ‘Education, Training & Development’ and ‘Management & Leadership’ knowledge and skills. The onus will be on students to assume responsibility for their development throughout this module. Assessment: Knowledge and skills will be assessed via submission of a portfolio of evidence to demonstrate performance at ‘Excellence’ level in the ACLF clusters 'Building Working Relationships', ‘Education, training and development’ and 'Management and Leadership'. Students will undertake a ‘viva voce’ based on their portfolio. The assessments will contribute to the overall module mark as follows: Portfolio Viva voce

50% 50%

Resources: E-learning website Workshops Supplementary notes: This learning outcomes and skills taught in this module are based on the competencies defined in the Advanced and Consultant Level Framework (ACLF) clusters 'Building Working Relationships', ‘Education, training and development’ and 'Management and Leadership'. The module has been designed to ensure that students achieve 'excellence' standard in the ACLF competencies. In addition, students will be facilitated in achieving ‘excellence’ standard in the ACLF cluster ‘Expert Professional Practice’ within their own specialist area of clinical practice.

36


Module Code: Module Title: Delivered by: CAT Points: Status: Pre-requisites: Co-requisites:

PMY7043 Practice Research Project Distance Learning Centre, School of Pharmacy 30 Pending approval PMY7041 (Research in Advanced Practice) PMY7042 (Advanced Practice Development)

Module description: This module follows the module PMY7041 (Research in Advanced Practice) and is designed to provide students with practical experience in designing and undertaking a practice research or development project within their workplace. Learning outcomes: On completion of this module, students will be able to: • • • • • •

Demonstrate the ability to critically evaluate and review relevant literature Demonstrate the ability to formulate a research or practice audit question Formulate an appropriate research or audit methodology Generate evidence suitable for presentation at a local level Demonstrate understanding of the principles of research governance Demonstrate the ability to manage a local research or practice audit project

Skills: Students will develop the following skills: • • • • •

Project management Scientific writing Critical evaluation Data collection and analysis Independent learning

Teaching and learning methods: Students are required to design a research protocol in collaboration with their QUB supervisor. Following agreement of the protocol, students are required to implement it within their workplace. Students are required to submit regular progress reports and drafts to their QUB supervisor. Assessment: Students are required to submit a dissertation of up to 10 000 words to report their research findings.

37


Resources: Each student will be allocated to a member of the School of Pharmacy academic staff, who will act as the academic supervisor. Supplementary notes: This learning outcomes and skills taught in this module are based on the competencies defined in the Advanced and Consultant Level Framework (ACLF) cluster 'Research and Evaluation'. The module has been designed to ensure that students achieve 'Foundation' standard in the ACLF competencies.

38


APPENDIX 3 PROGRAMME SPECIFICATION PG DIPLOMA IN ADVANCED PHARMACY PRACTICE (WITH INDEPENDENT PRESCRIBING)

39


Queen’s University Belfast PROGRAMME SPECIFICATION 1.

Programme title Advanced Pharmacy Practice (with Independent Prescribing)

2.

UCAS Code(s) (undergraduate programmes excluding minor honours) Not applicable

3.

4.

Programme Code (will be allocated online)

Awarding Institution Queen’s University Belfast

5.

6.

Teaching Institution (if different)

Programme Accredited by Pharmaceutical Society of Northern Ireland / Royal Pharmaceutical Society of Great Britain (Prescribing elements only)

7.

Final Award PG Diploma

8.

Relevant QAA Subject Benchmark Group(s) Not applicable

9.

Date of last revision (will be system-generated)

10.

Educational Aims of the Programme (3,500 character limit)

The aims of the PG Diploma in Advanced Pharmacy Practice (with Independent Prescribing) are to facilitate pharmacists in attaining ‘Excellence’ standard based on the competencies defined in the Advanced and Consultant Level Framework (ACLF) clusters ‘Expert Professional Practice’ and ‘Building Working Relationships’, and to enable graduates to register as Independent Prescribers with the Pharmaceutical Society of NI or the RPSGB. This programme provides advanced-level postgraduate education and training for pharmacists who complete the NI Hospital Pharmacists’ Vocational Training Scheme or for Band 7 hospital pharmacists who have sufficient accredited prior certificated or experiential learning (APCL/APEL), as judged by the School’s APL panel. A maximum of 60 credit points may be awarded for APL. The PG Diploma in Advanced Pharmacy Practice (with Independent Prescribing) will develop the student’s knowledge and skills to an advanced level in four key therapeutic areas: diabetes and common respiratory, cardiovascular and infectious diseases. In addition, students undertake the learning required to meet the learning outcomes defined by the PSNI/RPSGB syllabus for Independent Prescribers.

40


The PG Diploma in Advanced Pharmacy Practice (with Independent Prescribing) will be awarded to pharmacists who have demonstrated competence in providing specialist pharmaceutical care for patients with diabetes and common respiratory, cardiovascular and infectious diseases and also the competencies required to register as an Independent Prescriber.

11. The programme provides opportunities for learners to achieve and demonstrate the following outcomes (14,000 character limit) Knowledge and Understanding On completion, the student will be able to demonstrate knowledge and understanding of: • • • • • • • •

The pathophysiology, diagnosis, drug treatment and clinical management of diabetes and common respiratory, cardiovascular and infectious diseases Antimicrobial resistance and prevention and control of infection The influences on and psychology of prescribing The relevant aspects of basic and applied therapeutics The principles and methods of monitoring patients Evidence-based Practice and Clinical Governance The legal, policy, professional and ethical aspects of independent prescribing Prescribing in the public health context

Subject-specific Skills •

• • • • •

Planning, managing, monitoring and reviewing specialist pharmaceutical care programmes for patients with diabetes and common respiratory, cardiovascular and infectious diseases To be able to make prescribing decisions based on interpretation of monitoring parameters and knowledge of the disease state of the patient Prescribing in a team context Cost-effective prescribing Appropriate physical examination of the patient Development and delivery of Clinical Management Plans

Cognitive Skills • •

Students will develop their analytical, judgemental and interpretational skills and will be able to demonstrate the application of decision-making skills in complex situations Students will be able to recognise, evaluate and respond to influences on prescribing practice at individual, local and national levels

Transferable Skills • •

Effective consultation and decision-making skills The ability to learn in an independent manner

41


12.

The following teaching, learning and assessment methods are used to enable learners to achieve and demonstrate these outcomes (10,000 character limit)

Knowledge and Understanding Students complete 5 taught modules comprised of directed reading, workshops, e-learning and practice-based learning. Assessments are designed to test both knowledge and skills via a combination of coursework, MCQ examinations, OSCEs and submission of portfolios of evidence.

Subject-specific Skills Both the taught modules and the practice-based components are designed to equip the student with the practical skills required to practice clinical pharmacy at an advanced level and to become an effective independent prescriber. Advanced-level clinical pharmacy skills and physical examination skills are assessed via OSCE assessments for the modules PMY7040 (Advanced Therapeutics) and PMY7055 (Prescribing and Monitoring). In addition, students complete a period of practice-based prescribing training under the supervision of an approved medical practitioner.

Cognitive Skills Students learn the relevant theory in the taught modules. They learn to apply the theory in practice in the workshop components and the practice-based training component. Students are required to provide a portfolio of evidence that demonstrates their competency as an Independent Prescriber. The portfolio must be signed off by the student’s Designated Medical Practitioner.

Transferable Skills Students are required to demonstrate effective consultation and decision making skills in the OSCE assessments for the modules PMY7040 (Advanced Therapeutics) and PMY7055 (Prescribing and Monitoring). PMY7056 (Disease Management) utilises a self-directed learning format whereby students are required to plan and implement their own learning schedule. This is assessed via a portfolio of evidence.

42


13.

Programme structure, levels, modules and credits

Indicate for each stage if modules are compulsory or optional. Also indicate if optional modules are to be taken from identified groups. Indicate how many modules are to be taken at each stage. Stage Category

Code Title

Pre-requisites

CATS

(compulsory/optional)

Status (live/suspended)

Compulsory

PMY7040 Advanced Therapeutics

None

20

Pending

Compulsory

PMY7054 Clinical Management Planning

None

10

Live

Compulsory

PMY7055 Prescribing and Monitoring

None

10

Live

Compulsory

PMY7056 Disease Management

None

10

Live

Compulsory

PMY7057 Professional Aspects

None

10

Live

14.

Awards and Progression (11,000 character limit)

The PG Diploma in Advanced Pharmacy Practice (with Independent Prescribing) is awarded to students who have been awarded 60 points via credit transfer and who have completed and passed the compulsory modules, totalling 120 credit points. Alternatively, on passing the compulsory modules, the student may progress to the MSc in Advanced Pharmacy Practice (with Independent Prescribing). The University’s ‘Regulations for Taught Postgraduate Programmes’ will be applied to this programme – see General Regulations: University Calendar (available from http://www.qub.ac.uk/directorates/AcademicStudentAffairs/AcademicAffairs/

43


15.

Criteria for Admission to the Programme (2,500 character limit)

For current University entry requirements for this programme go to www.qub.ac.uk/ado Subject specific requirements for this programme are: • • •

16.

Current registration with the Pharmaceutical Society of Northern Ireland and/or Royal Pharmaceutical Society of Great Britain Support from the sponsoring organisation e.g. an NHS Trust Have a named medical practitioner, recognised by the employing/Health Service commissioning organization a) as having experience in a relevant field of practice, b) training and experience in the supervision, support and assessment of trainees, c) who has agreed to; - provide the student with opportunities to develop competencies in prescribing - supervise, support and assess the student during the clinical placement element.

Additional relevant information (3,500 character limit)

This course is delivered by a combination of distance learning, e-learning, work-based learning, on-campus workshops and prescribing training with a mentor. Support for distance learning is provided via the following mechanisms: • • • • • •

17.

Student handbook detailing contact information, course structure and format, requirements for progression, administrative and module information. Telephone / e-mail access to full-time Distance Learning Centre staff during working hours Online web pages provide additional resources for students, including discussion forums where students may communicate with each other Access to electronic journals via QUB library web pages Written feedback provided on written assignments Instant feedback on computer-based assessments.

Further information about the programme is available from

School of Pharmacy web pages: http://www.qub.ac.uk/pha/dl Northern Ireland Centre for Pharmacy Learning and Development (NICPLD) web pages: http://www.nicpld.org

44


APPENDIX 4 PROGRAMME SPECIFICATION MSc IN ADVANCED PHARMACY PRACTICE (WITH INDEPENDENT PRESCRIBING)

45


Queen’s University Belfast PROGRAMME SPECIFICATION 1.

Programme title Advanced Pharmacy Practice (with Independent Prescribing)

2.

UCAS Code(s) (undergraduate programmes excluding minor honours) Not applicable

3.

4.

Programme Code (will be allocated online)

Awarding Institution Queen’s University Belfast

5.

6.

Teaching Institution (if different)

Programme Accredited by Pharmaceutical Society of Northern Ireland / Royal Pharmaceutical Society of Great Britain (Prescribing elements only)

7.

Final Award MSc

8.

Relevant QAA Subject Benchmark Group(s) Not applicable

9.

Date of last revision (will be system-generated)

10.

Educational Aims of the Programme (3,500 character limit)

The aims of the MSc in Advanced Pharmacy Practice (with Independent Prescribing) are to facilitate pharmacists in attaining ‘Excellence’ standard based on the competencies defined in the Advanced and Consultant Level Framework (ACLF), and to enable graduates to register as Independent Prescribers with the Pharmaceutical Society of NI or the RPSGB. This programme provides advanced-level postgraduate education and training for pharmacists who complete the NI Hospital Pharmacists’ Vocational Training Scheme or for Band 7 hospital pharmacists who have sufficient accredited prior certificated or experiential learning (APCL/APEL), as judged by the School’s APL panel. A maximum of 60 credit points may be awarded for APL. Students complete 8 modules over a 30 month period. The aim of the first 5 modules is to develop the student’s knowledge and skills to an advanced level in four key therapeutic areas: diabetes and common respiratory, cardiovascular and infectious diseases. In addition, students undertake the learning required to meet the learning outcomes defined by the PSNI/RPSGB syllabus for Independent Prescribers. On completion of the first 5 modules (equivalent to the PG Diploma), students will be expected to demonstrate ‘Excellence’ standard based on the competencies defined in the ACLF clusters ‘Expert Professional Practice’ and ‘Building Working Relationships’. The aim of the remaining 3 modules is to further develop advanced-level practice and research skills. On completion students will be

46


expected to demonstrate ‘Excellence’ standard based on the competencies defined in the ACLF clusters 'Research and Evaluation', 'Building Working Relationships', ‘Education, training and development’ and 'Management and Leadership'. The MSc in Advanced Pharmacy Practice (with Independent Prescribing) will be awarded to pharmacists who have demonstrated competence in all six of the ACLF clusters and also the competencies required to register as an Independent Prescriber.

11. The programme provides opportunities for learners to achieve and demonstrate the following outcomes (14,000 character limit) Knowledge and Understanding On completion, the student will be able to demonstrate knowledge and understanding of: • • • • • • • • •

The pathophysiology, diagnosis, drug treatment and clinical management of diabetes and common respiratory, cardiovascular and infectious diseases Antimicrobial resistance and prevention and control of infection The influences on and psychology of prescribing The relevant aspects of basic and applied therapeutics The principles and methods of monitoring patients Evidence-based Practice and Clinical Governance The legal, policy, professional and ethical aspects of independent prescribing Prescribing in the public health context The formulation of research hypotheses and the methodologies used to test them

Subject-specific Skills •

• • • • • • •

Planning, managing, monitoring and reviewing specialist pharmaceutical care programmes for patients with diabetes and common respiratory, cardiovascular and infectious diseases To be able to make prescribing decisions based on interpretation of monitoring parameters and knowledge of the disease state of the patient Prescribing in a team context Cost-effective prescribing Appropriate physical examination of the patient Development and delivery of Clinical Management Plans Statistical techniques applicable to pharmacy practice research and development Research ethics considerations applicable to pharmacy practice research and development

Cognitive Skills • •

Students will develop their analytical, judgemental and interpretational skills and will be able to demonstrate the application of decision-making skills in complex situations Students will be able to recognise, evaluate and respond to influences on prescribing practice at individual, local and national levels

Transferable Skills • • • • •

Effective consultation and decision-making skills The ability to learn in an independent manner Management and leadership skills including strategic planning, managing change and resources utilisation Working in a multidisciplinary team The ability to plan and undertake the education, training and development of colleagues

47


• • •

12.

The ability to write for a scientific audience The ability to manage a project within the allocated timescale The ability to critically evaluate clinical and scientific literature

The following teaching, learning and assessment methods are used to enable learners to achieve and demonstrate these outcomes (10,000 character limit)

Knowledge and Understanding Students complete 6 taught modules comprised of directed reading, workshops, e-learning and practice-based learning. Assessments are designed to test both knowledge and skills via a combination of coursework, MCQ examinations, OSCEs and submission of portfolios of evidence. In PMY7042 (Advanced Practice Development), students develop a Personal Development Plan and assume responsibility for their own development during the module. Students submit a portfolio of evidence and undertake a ‘viva voce’ based on their portfolio. In addition, students undertake a 12 month practice research or development project within their workplace and submit a research dissertation in the module PMY7043 (Practice Research Project).

Subject-specific Skills Both the taught modules and the practice-based components are designed to equip the student with the practical skills required to practice clinical pharmacy at an advanced level and to become an effective independent prescriber. Advanced-level clinical pharmacy skills and physical examination skills are assessed via OSCE assessments for the modules PMY7040 (Advanced Therapeutics) and PMY7055 (Prescribing and Monitoring). In addition, students complete a period of practice-based prescribing training under the supervision of an approved medical practitioner. In PMY7041 (Research in Advanced Practice), students are required to demonstrate that they can select and undertake appropriate statistical analysis of pharmacy practice research data and the ability to draw appropriate conclusions. In addition, students will be required to develop a pharmacy practice research protocol that complies with the requirements of NHS Ethics Committees.

Cognitive Skills Students learn the relevant theory in the taught modules. They learn to apply the theory in practice in the workshop components and the practice-based training component. Students are required to provide a portfolio of evidence that demonstrates their competency as an Independent Prescriber. The portfolio must be signed off by the student’s Designated Medical Practitioner.

Transferable Skills Students are required to demonstrate effective consultation and decision making skills in the OSCE assessments for the modules PMY7040 (Advanced Therapeutics) and PMY7055 (Prescribing and Monitoring). The modules PMY7056 (Disease Management) and PMY7042 (Advanced Practice Development) utilise a self-directed learning format whereby students are required to plan and implement their own learning schedules. These are assessed via portfolios of evidence and a ‘viva voce’ assessment (PMY7042). The module PMY7043 (Practice Research Project) requires students to develop and undertake a pharmacy practice research or development project. The module is assessed via submission of a dissertation of up to 10 000 words.

48


13.

Programme structure, levels, modules and credits

Indicate for each stage if modules are compulsory or optional. Also indicate if optional modules are to be taken from identified groups. Indicate how many modules are to be taken at each stage. Stage: PG Diploma Category

Code Title

Pre-requisites

CATS

(compulsory/optional)

Status (live/suspended)

Compulsory

PMY7040 Advanced Therapeutics

None

20

Pending

Compulsory

PMY7054 Clinical Management Planning

None

10

Live

Compulsory

PMY7055 Prescribing and Monitoring

None

10

Live

Compulsory

PMY7056 Disease Management

None

10

Live

Compulsory

PMY7057 Professional Aspects

None

10

Live

Stage: MSc Category

Code Title

Pre-requisites

CATS

(compulsory/optional)

Status (live/suspended)

Compulsory

PMY7041 None Research in Advanced Practice

10

Pending

Compulsory

PMY7042 None Advanced Practice Development

20

Pending

Compulsory

PMY7043 Practice Research Project

30

Pending

14.

PMY7041

Awards and Progression (11,000 character limit)

The MSc in Advanced Pharmacy Practice (with Independent Prescribing) is awarded to students who have been awarded 60 points via credit transfer and who have completed and passed the 8 compulsory modules, totalling 180 credit points. Alternatively, on passing the first 5 modules, the student may graduate with a PG Diploma in Advanced Pharmacy Practice (with Independent Prescribing). The University’s ‘Regulations for Taught Postgraduate Programmes’ will be applied to this programme – see General Regulations: University Calendar (available from http://www.qub.ac.uk/directorates/AcademicStudentAffairs/AcademicAffairs/)

49


15.

Criteria for Admission to the Programme (2,500 character limit)

For current University entry requirements for this programme go to www.qub.ac.uk/ado Subject specific requirements for this programme are: • • •

16.

Current registration with the Pharmaceutical Society of Northern Ireland and/or Royal Pharmaceutical Society of Great Britain Support from the sponsoring organisation e.g. an NHS Trust Have a named medical practitioner, recognised by the employing/Health Service commissioning organization a) as having experience in a relevant field of practice, b) training and experience in the supervision, support and assessment of trainees, c) who has agreed to; - provide the student with opportunities to develop competencies in prescribing - supervise, support and assess the student during the clinical placement element.

Additional relevant information (3,500 character limit)

This course is delivered by a combination of distance learning, e-learning, work-based learning, on-campus workshops and prescribing training with a mentor. Support for distance learning is provided via the following mechanisms: • • • • • • •

17.

Student handbook detailing contact information, course structure and format, requirements for progression, administrative and module information. Telephone / e-mail access to full-time Distance Learning Centre staff during working hours Online web pages provide additional resources for students, including discussion forums where students may communicate with each other Access to electronic journals via QUB library web pages Written feedback provided on written assignments Instant feedback on computer-based assessments Academic supervisor for the module PMY7043 (Practice Research Project)

Further information about the programme is available from

School of Pharmacy web pages: http://www.qub.ac.uk/pha/dl Northern Ireland Centre for Pharmacy Learning and Development (NICPLD) web pages: http://www.nicpld.org

50


APPENDIX 5 PROGRAMME LEARNING OUTCOMES MAPPED TO MODULES

51


APPENDIX 6 MARKET INTELLIGENCE REPORT

55


Market Intelligence Course: School: Date:

MSc Advanced Pharmacy Practice School of Pharmacy 19 June 2009

Introduction Marketing and Communications was tasked with carrying out market intelligence on a proposed MSc in Advanced Pharmacy Practice. As Advanced Pharmacy Practice is a specialist postgraduate Pharmacy course, statistics are not available on student numbers however statistics showing student numbers for general Pharmacy postgraduate taught courses could offer some insight into the potential demand for this new course. Pharmacy Statistics The charts below detail the numbers of new entrants into postgraduate taught courses in Pharmacy (JACS code B2 – Pharmacology, Toxicology and Pharmacy) in the UK over the last six years.

Source: www.hesa.ac.uk, www.britishcouncil.org • •

The number of first year Home and EU postgraduate taught students studying Pharmacy has increased by 81% over the past six years. The number of first year non-EU postgraduate taught students in Pharmacy has increased by 194% over the past six years.

56


The table below illustrates the top 5 overseas (non-EU) countries where students are coming from to study a postgraduate taught course in Pharmacy in the UK:

2003/04 1 2

2004/05

2005/06

3

India - 165 Hong Kong 65 China – 40

India – 225 Hong Kong – 75 China - 50

India - 305 Hong Kong – 75 Nigeria – 55

4

Nigeria – 30

Nigeria - 50

Pakistan – 45

5

Pakistan - 20

Pakistan - 25

China - 35

2006/07 India – 555 Nigeria – 65 Pakistan – 60 Saudi Arabia – 20 China - 20

2007/08 India – 600 Malaysia – 135 Nigeria – 60 Pakistan - 45 Saudi Arabia 35

Source: www.britishcouncil.org

India is, by a considerable distance, the country from which most overseas students studying postgraduate taught courses in Pharmacy in the UK are sourced. The number of students from India has increased significantly over the past few years. International recruitment efforts could therefore be focused on this market.

Competitor Analysis •

Within the UK, 7 postgraduate courses similar to that proposed by Queen’s were identified. These courses are illustrated in the table below: University University of Reading

Degree offered MSc Advanced Pharmacy Practice (currently under development)

University of Hertfordshire

MSc Advancing Pharmacy Practice MSc Advanced Professional Practice MSc Pharmacy Practice MSc Pharmacy Practice MSc Clinical Pharmacy Practice MSc Pharmacy Practice

University of Keele University of Portsmouth University of London University of Brighton University of Leeds •

The University of Reading’s course in Advanced Pharmacy Practice appears to be the most similar course to that proposed by Queen’s. This course is still under development at this time.

Further detailed competitor analysis is provided in Appendix 1.

Conclusion •

Demand for postgraduate taught courses in Pharmacy has increased significantly over the past six years among both Home/EU and International students. This suggests a growing market for this type of course.

57


• •

There were few examples found however of universities offering this particular course in Advanced Pharmacy Practice. This course has been proposed as an alternative route to an MSc in response to a request from Trust Pharmacy Managers and the School of Pharmacy has been working with Trust Pharmacy Managers to develop the new course. This suggests that a need for the course has been identified.

58


Appendix 1 – Additional Competitor Analysis

University of Reading MSc Advanced Pharmacy Practice (this programme is currently under development) Entry criteria: Not specified

Facilities and selling points emphasized: • The modules are developed for inter-professional learning to encourage team working within the NHS. They are presented as "blended learning" requiring some face to face attendance and some distance learning and self-study. • A work based learning module enables pharmacists to achieve recognition of professional development at work. Course content: Not specified Bursaries and scholarships available: No subject specific scholarships specified Study routes: Not specified Fees: Not specified

59


University of Hertfordshire MSc Advancing Pharmacy Practice Entry criteria: Applicants must be registered pharmacists, ideally with 1-2 years practice, and have a second class honours degree in Pharmacy or equivalent.

Facilities and selling points emphasized: • Flexibility of choosing different modules • The programme offers inter-professional working opportunities • Work placements for international students • The School of Pharmacy facilities including a sterile suite and simulated pharmacy Course content: Full-time Pathway: Compulsory modules: Evidence-based practice and work related learning plus two from regulation of medicines, (60 credits) patient safety, therapeutics and pharmacovigilence Compulsory research: Research methods and Health Disciplines Project (60 credits) Optional: See list of optional modules Part-time Pathway (UK) only Compulsory 60 credits research element and accumulation of credits via accredited modules. Accumulation of 180 credits will result in the award of an MSc. Core modules: •

Evidence Based Practice

Healthcare Disciplines Project

Research Methods

Work Based Study:Professional Issues Related to Healthcare Practice

Optional modules: •

Challenges in Child Development, Recognition, Diagnosis and Care

Clinical Governance and Medicines Management

Diagnostic Dilemmas in Child Health and Medical Practice

Inter-Professional Working in Health and Social Care

Leadership in Practice

Patient Safety

Pharmaceutical Law

60


• •

Pharmacist Independent Prescribing Pharmacist Independent Prescribing M

Pharmacovigilance

Preparation for Mentorship

Preparation for Mentorship

Project

Regulations of Medicines

Risk Management (Pharmacy)

Safeguarding Children Through Advanced Health and Medical Practice

Strategic Development for Health Improvement

Therapeutic Interventions in Primary Care

Therapeutics

Work-Based Learning

Bursaries and scholarships available: No subject specific scholarships specified Study routes: Part-time short course modules building to an MSc qualification, full-time 1 year Fees: Full-time – Home/EU - £3833, Non-EU - £9000, Part-time – Home/EU - £310 per module

61


University of Keele MSc Advanced Professional Practice Entry criteria: Not specified

Facilities and selling points emphasized: • The postgraduate Advanced Professional Practice Programme is designed to allow pharmacists and other health professionals, particularly medical and non-medical prescribers working in primary care, choice and flexibility in their progression to Certificate, Diploma and Masters awards to meet their specific professional development needs and advance their professional practice. •

Pharmacists can choose modules from across the Department of Medicines Management/School of Pharmacy postgraduate programmes’ portfolio, including Community Pharmacy and Clinical (Hospital) Pharmacy.

Course content: All the courses/modules from Prescribing Studies, Community Pharmacy, Clinical Pharmacy and others provided by Keele can be ‘picked and mixed’ towards a Certificate or Diploma in Advanced Professional Practice. Bursaries and scholarships available: No subject specific scholarships specified Study routes: Primarily provided via distance learning Fees: £1995 per annum

62


University of Portsmouth MSc Pharmacy Practice Entry criteria: Pharmacy degree (BSc, BPharm or MPharm) with a minimum classification of 2.2, registration as a practising pharmacist with the RPSGB and a practice-base (i.e. paid employment at an accredited centre).

Facilities and selling points emphasized: • The programme will be delivered by the School of Pharmacy and Biomedical Sciences at the University of Portsmouth. However, it has been developed in conjunction with four other Schools of Pharmacy – the University of London, King’s College London, the University of Brighton and the University of East Anglia – allowing a broad range of expertise to be used. The development of a joint syllabus also provides an opportunity for transferable credit between universities Course content: Year one: Community pharmacy: Applied Pharmacy Practice Skills, Pharmacy Practitioner Development in the NHS – including MUR, medication review and response to symptoms Hospital pharmacy: Applied Pharmacy Practice Skills, Pharmacy Practitioner Development in the NHS – including patient and clinical monitoring, health policy and pharmaceutical care Primary care: Applied Pharmacy Practice Skills, Pharmacy Practitioner Development in the NHS – including prescribing support Year two: Year two units are the same for all three areas of practice and include a detailed investigation of applied therapeutics and pharmaceutical care relevant to patient groups within the student’s particular area of pharmacy practice. Year three: Optional units in year three include: Prescribing, Public Health, Extended and Advanced Services, Facilitation Skills, Critical Care, Cardiovascular Care, Learning and Teaching Bursaries and scholarships available: No subject specific scholarships specified Study routes: The course is a three-year, part-time programme (one day per week or fortnight, depending on the stage of the course, or evenings for community pharmacist participants). Fees: Home/ EU - £2050 per annum, international - £3560 per annum

63


University of London MSc Pharmacy Practice Entry criteria: Applicants must be a practicing pharmacist in a Band 8 post and have completed the Postgraduate Certificate and Diploma in Pharmacy Practice at the School of Pharmacy, University of London, or equivalent from another University (at discretion of the Course Director); or provide a portfolio of evidence of prior learning and experience and undergo a formal interview with an approved APL/APEL panel. Facilities and selling points emphasized: • The learning outcomes for this programme are underpinned by the ACLF (Advanced to Consultant Level Framework http://www.codeg.org/ ). • The programme will support further development of self reliance and an independent approach to learning in support of professional development Course content: The MSc programme is organised as: • • •

10 half-day learning sets every 4 or 5 weeks. A series of ACLF-linked assignments. Professional development assessments linked to ACLF progression.

Further details not provided Bursaries and scholarships available: No subject specific scholarships specified Study routes: There will be 10 half-day learning sets, and a requirement for completion of a series work-based project(s) over 12 to 18 months, mapped against the ACLF. Fees: £2,100

64


University of Brighton MSc Clinical Pharmacy Practice Entry criteria: At least one year post-registration experience in hospital pharmacy and currently in practice. PGDip selection by portfolio and interview. Additional interview for MSc year. Facilities and selling points emphasized: • A long-established collaborative venture between the school and some of the teaching and specialist hospitals in London and the South-east ensures a high quality of theory delivery together with practical clinical experience. Course content: PGDip: Consultation Skills for Medication Review NHS Policy and Pharmacy Practice General Therapeutics Managing Health Risk Specialised Therapeutics MSc: Self-development assignment Research Methodology Research project Bursaries and scholarships available: No subject specific scholarships specified Study routes: The PGDip requires attendance one day per week, plus blocks in September, November and April. The MSc involves a self-development assignment, a research methodology course and a research project. Fees: £3780 per year

65


University of Leeds MSc Pharmacy Practice Entry criteria: Ability to study at level M (normally an Honours degree). A pharmacist with current registration with the Royal Pharmaceutical Society of Great Britain or Pharmaceutical Society of Northern Ireland (RPSGB or PSNI). Agreed appropriate access to pharmacy practice to allow the undertaking of work-based assignments. Appointment of a work-based tutor, mutually agreed by student, programme manager and work-based manager. Facilities and selling points emphasized: • Part-time programme to help pharmacists develop the knowledge and skills needed to meet the challenges presented by developments in pharmacy practice Course content: PGCert: Personal and Professional Development in Healthcare, and Pharmaceutical Care for Patients with Long-term Conditions PGDip: As above, plus Service Development in Healthcare, and Pharmaceutical Care for Patients with Acute Conditions MSc: As above, plus Research Methods, or Research Methodology, and dissertation/practice- based project Bursaries and scholarships available: No subject specific scholarships specified Study routes: Part-time Fees: £1650 per annum part-time

66


QUB